Search results for: Amanda Cole
Filter search results
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…industry, and crucially people affected by cancer – to develop a shared vision on this topic for the first time.” Cole, A., Cubi-Molla, P., Pollard, J., Sim, D., Sullivan, R.,…
Data Governance Arrangements for Real-world Evidence in Japan
12 September 2019
…Challenges. Journal of Comparative Effectiveness Research, 7(12), pp.1133-43. DOI. RePEc. Lee,E.K., Park,J.A., Cole,A. and Mestre-Ferrandiz,J., 2017. Data Governance Arrangements for Real-World Evidence in South Korea. OHE Consulting Report, London: Office…
Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers?
20 December 2018
…and underpins our legal frameworks. Cole, A. and Towse, A., 2018. Legal Barriers to Better the Better Use of Health Data to Deliver Pharmaceutical Innovation. OHE Consulting Report, London: Office…
Cornerstones of ‘Fair’ Drug Coverage
30 September 2020
…available here. It is also available on the ICER website here. Related Research Pearson SD, Segel C, Cole A, Henshall C, and Towse A. 2019. Policy perspectives on alternative…
Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System
31 March 2021
…2020. Cornerstones of “Fair” Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals. ICER and OHE. Available at https://www.ohe.org/publications/cornerstones-%E2%80%9Cfair%E2%80%9D-drug-coverage-appropriate-cost-sharing-and-utilization-management Pearson SD, Segel C, Cole A, Henshall C, and Towse…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…Hideo Yasunaga and Hayato Yamana through desk research, using the same pre-specified pro-forma as for the previous reports. 1 Cole,A., Garrison,L., Mestre-Ferrandiz,J., Towse,A., 2015. Data Governance Arrangements for Real-World Evidence.OHE…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…Cole, A. & Towse, A. & Lorgelly, P. & Sullivan, R., 2018. Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals. OHE Research Paper. London: Office of Health…
OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018
5 November 2018
…Establishing a Reasonable Price for an Orphan Drug. OHE Research Paper 18/05, London: Office of Health Economics. Available at: https://www.ohe.org/publications/establishing-reasonable-price-orphan-drug#. Cole, A., Towse, A., Lorgelly, P. and Sullivan, R. (2018)….
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
…10 Nov, 15:30–19:30) NICE’s effect on innovation and access to medical technologies 2. Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? Amanda Chapman (OHE, presenting), Celia…